Top

Published in:

01-02-2021 | Aneurysm | Case Report

Coronary Artery Dilation in an Asymptomatic Pediatric Patient with COVID19 Antibodies

Authors: Nicole Gerber, Patrick A. Flynn, Ralf J. Holzer

Published in: Pediatric Cardiology | Issue 2/2021

Abstract

We describe a 16-year-old asymptomatic male who presented with coronary artery dilation (z score + 2.3) identified on echo performed solely for presence of COVID-19 antibodies. This case raises the question of whether cardiac screening should be considered for all patients with a history of COVID-19.

Colan S (2009) Normal echocardiographic values for cardiovascular structures. In: Lai W, Cohen M, Genva T, Mertens L (eds) Echocardiography in pediatric and congenital heart disease. Wiley-Blackwell, West Sussex, pp 765–785

Liu PP, Blet A, Smyth D, Li H (2020) The science underlying covid-19: implications for the cardiovascular system. Circulation. https://doi.org/10.1161/circulationaha.120.047549CrossRefPubMed

Sanna G, Serrau G, Bassareo PP, Neroni P, Fanos V, Marcialis MA (2020) Children’s heart and COVID-19: up-to-date evidence in the form of a systematic review. Eur J Pediatr 179(7):1079–1087. https://doi.org/10.1007/s00431-020-03699-0CrossRefPubMed

Feldstein LR, Rose EB, Horwitz SM et al (2020) multisystem inflammatory syndrome in US children and adolescents. N Engl J Med. 383(4):334–346. https://doi.org/10.1056/nejmoa2021680CrossRefPubMed

Phelan D, Kim JH, Chung EH (2020) A game plan for the resumption of sport and exercise after coronavirus disease 2019 (COVID-19) infection. JAMA Cardiol 5(10):1085–1086. https://doi.org/10.1001/jamacardio.2020.2136CrossRef

Baggish A, Drezner JA, Kim J, Martinez M, Prutkin JM (2020) Resurgence of sport in the wake of COVID-19: cardiac considerations in competitive athletes. Br J Sports Med 54(19):1130–1131. https://doi.org/10.1136/bjsports-2020-102516CrossRefPubMedPubMedCentral

Dores H, Cardim N (2020) Return to play after COVID-19: a sport cardiologist’s view. Br J Sports Med 54(19):1132–1133. https://doi.org/10.1136/bjsports-2020-102482CrossRefPubMed

Dean PN, Jackson L, Paridon SM. Returning To Play After Coronavirus Infection : Pediatric Cardiologists ’ Perspective. Am Coll Cardiol.:1–6. https://www.acc.org/latest-in-cardiology/articles/2020/07/13/13/37/returning-to-play-after-coronavirus-infection. Accessed 2 Nov 2020.

Pinches H, Dobbins K, Cantrell S, May J, Lopreiato J (2016) Asymptomatic Kawasaki disease in a 3-month-old infant. Pediatrics. https://doi.org/10.1542/peds.2015-3936CrossRefPubMed

10.

McCrindle BW, Rowley AH, Newburger JW et al (2017) Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the american heart association. Circulation 135(17):e927–e999. https://doi.org/10.1161/CIR.0000000000000484CrossRefPubMed

11.

Orenstein JM, Shulman ST, Fox LM et al (2012) Three linked vasculopathic processes characterize Kawasaki disease: a light and transmission electron microscopic study. PLoS ONE. https://doi.org/10.1371/journal.pone.0038998CrossRefPubMedPubMedCentral

12.

Kato H, Sugimura T, Akagi T et al (1996) Long-term consequences of Kawasaki disease: a 10- to 21-year follow-up study of 594 patients. Circulation 94(6):1379–1385. https://doi.org/10.1161/01.CIR.94.6.1379CrossRefPubMed

Title: Coronary Artery Dilation in an Asymptomatic Pediatric Patient with COVID19 Antibodies
Authors: Nicole Gerber
Patrick A. Flynn
Ralf J. Holzer
Publication date: 01-02-2021
Publisher: Springer US
Keywords: Aneurysm
Aneurysm
COVID-19
Published in: Pediatric Cardiology / Issue 2/2021
Print ISSN: 0172-0643
Electronic ISSN: 1432-1971
DOI: https://doi.org/10.1007/s00246-021-02566-5

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

At a glance: The STEP trials

Springer Medicine

Coronary Artery Dilation in an Asymptomatic Pediatric Patient with COVID19 Antibodies

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2021

Impact of Reverse Left Ventricular Remodeling on Outcomes of Patients with Anomalous Left Coronary Artery from the Pulmonary Artery after Surgical Correction

Impact of Annulus-Sparing on Surgical Adequacy of Pulmonary Valve in Complete Repair of Tetralogy of Fallot with Right Ventricular Outflow Tract Incision

Right Ventricular Remodeling in Hypoplastic Left Heart Syndrome is Minimally Impacted by Cardiopulmonary Bypass: A Comparison of Norwood vs. Hybrid

Clinical Implications of Fragmented QRS Complex as an Outcome Predictor in Children with Idiopathic Dilated Cardiomyopathy

Hemodynamics under General Anesthesia in Glenn/Fontan Circulation?

Pediatric Myocardial T1 and T2 Value Associations with Age and Heart Rate at 1.5 T

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page